Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Bayan Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Bayan Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 214 · Grade C

Bayan Health

Visit Bayan Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Bayan Health a bad call — it's best for shoppers who want a flat dose price and are ready to commit to a full treatment protocol rather than a single month. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
74
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
72
Track Record
88
62
CoreAge RxBrief Score 94 · 67Bayan Health

Price, coverage & the tracker

CoreAge RxBayan Health
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $129/mo (all doses, protocol commitment, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $149/mo (all doses, protocol commitment, compounded)

CoverageUS only; restrictions by state, confirmed at intakeNationwide claimed, no state list published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Bayan Health: Listed price: From $129/mo (all doses, protocol commitment, compounded). Confirm the complete billing term and renewal amount.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.